When does Valneva (VLA.PA stock) announce Q4 results?

Valneva's Q4 earnings are scheduled for **18 Mar 2026** after the market close. Expect commentary on vaccine sales, R&D progress for VLA1553 and any updated guidance that could move VLA.PA stock in the following trading session.

What is Meyka AI's price forecast for VLA.PA stock?

Meyka AI's forecast model projects a yearly price of **EUR 5.30** for VLA.PA stock, implying a **16.48%** upside versus the current **EUR 4.55**. Forecasts are model-based projections and not guarantees.

Which metrics matter most in the upcoming VLA.PA earnings report?

Key metrics are revenue growth, gross margin, guidance on vaccine sales, operating cash flow and R&D updates for chikungunya and Lyme candidates. EPS and cash runway commentary will shape near-term VLA.PA stock volatility.

How liquid is VLA.PA stock ahead of earnings?

Intraday volume is **337,265** against an average of **1,029,996**, giving relative volume near **0.91**. That suggests lower participation and potential for sharper moves when news hits.

EU Stocks

VLA.PA Valneva EURONEXT up 0.98% intraday ahead of Q4 16 Mar 2026: earnings to watch

ByDanny Kontos March 16, 2026March 16, 2026

Valneva SE (VLA.PA) is trading at EUR 4.55 intraday on EURONEXT, up 0.98%, as investors focus on its Q4 earnings due 18 Mar 2026. The market is watching sales mix for IXIARO and clinical progress on VLA1553 and VLA15. VLA.PA stock carries a negative EPS of -0.65 and a trailing PE of -6.99, making guidance and pipeline commentary the likely drivers of short-term moves.